top of page
WorkPackage1-Banner.jpg

CLINICAL EVIDENCE

Developing International Standards for IVD Performance Evaluation

The Challenge

Regulatory authorities updated their requirements for manufacturers to demonstrate that diagnostics will have good performance in clinical practice. Good practice for generating data gathered in patients is well established for drugs, but is less established for diagnostics. The lack of international guidance for diagnostics performance evaluation is a barrier to efficient development and introduction of new diagnostics in clinical practice.

Our Focus

WP1 strengthens the foundations of diagnostic regulation by improving how regulatory evidence is developed, structured, and justified.
 

We will:
 

  • Evaluate the need for development of an international standard for diagnostic performance.
     

  • Propose our leadership in a collaborative initiative for a new standard within the international standards organisation ISO.
     

  • Develop a draft document to guide state of the art methods for performance evaluation of diagnostics.

Why It Matters

Clearer, evidence-led standards for evaluation supports better regulatory decisions, reduces unnecessary delays, and gives innovators confidence about what is required.

What Success Looks Like

Advancing agreement on international standards on scientific evidence required to evaluate performance of diagnostics. An international standard will harmonise evidence requirements, cut duplication, and support faster, more consistent regulatory decisions – improving efficiency for manufacturers and access for patients.

  • LinkedIn

© 2026 by CERSI IVD. All rights reserved.

CERSI-IVD: Centre of Excellence for Regulatory Science and Innovation (CERSIs) of In Vitro Diagnostic (IVD) tests. Clinical Evaluation and Assessment for Regulation of In Vitro Diagnostic tests (CLEARED IVD).

bottom of page